KRAS and lung adenocarcinoma: Cre-dependent somatic activation of oncogenic Kras (G12D) in combination of CRISPR/Cas9 mediated genome editing led to the generation of lung adenocarcinomas in mouse models which enabled the functional characterization of putative cancer genes [93].